Phase 1 Safety and Efficacy of AZD8630/AMG 104 Inhaled Anti-TSLP inHealthy Volunteers and Patients With Asthma on Medium-High DoseInhaled Corticosteroid (ICS) and Long-Acting Beta-agonist (LABA) WithElevated Baseline Fractional Exhaled Nitric Oxide (FeNO)

Article Details

Citation

Copy to clipboard

Doffman S, Dosanjh D, Sadiq MW, Asimus S, Cooper J, Zhou X, Seth H, Pandya HC, Saralaya D, Beier J, Forsman H

Phase 1 Safety and Efficacy of AZD8630/AMG 104 Inhaled Anti-TSLP inHealthy Volunteers and Patients With Asthma on Medium-High DoseInhaled Corticosteroid (ICS) and Long-Acting Beta-agonist (LABA) WithElevated Baseline Fractional Exhaled Nitric Oxide (FeNO)

.

PubMed ID

Not Available

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

AZD8630

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
AZD8630	Thymic stromal lymphopoietin	Protein	Humans	Yes	Antibody	Details